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The number of pediatric kidney transplants has been increasing in many centers worldwide, as the procedure
provides long-lasting and favorable outcomes; however, few papers have addressed the immediate
postoperative care of this unique population. Herein, we describe the management of these patients in the
early postoperative phase. After the surgical procedure, children should ideally be managed in a pediatric
intensive care unit, and special attention should be given to fluid balance, electrolyte disturbances and blood
pressure control. Antibiotic and antiviral prophylaxes are usually performed and are based on the recipient and
donor characteristics. Thrombotic prophylaxis is recommended for children at high risk for thrombosis,
although consensus on the optimum therapy is lacking. Image exams are essential for good graft control, and
Doppler ultrasound must be routinely performed on the first operative day and promptly repeated if there is
any suspicion of kidney dysfunction. Abdominal drains can be helpful for surveillance in patients with increased
risk of surgical complications, such as urinary fistula or bleeding, but are not routinely required. The
immunosuppressive regimen starts before or at the time of kidney transplantation and is usually based on
induction with monoclonal or polyclonal antibodies, depending on the immunological risk, and maintenance
with a calcineurin inhibitor (tacrolimus or ciclosporin), an anti-proliferative agent (mycophenolate or
azathioprine) and steroids.
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& INTRODUCTION
Kidney transplantation is the gold standard treatment for
pediatric patients with end-stage renal disease (ESRD).
Transplantation provides better survival, lower morbidity
and better quality of life compared with dialysis therapy for
this patient population (1). Although improvements in the
surgical technique and in the immunosuppressive drugs
have increased the graft survival rate (2,3), there are still
some issues regarding the best management, particularly for
younger children, during the postoperative period. Several
studies have addressed the surgical aspects and immuno-
suppressive therapies for children who are candidates for
kidney transplantation (4); however, little data concerning
the immediate postoperative care of these transplanted
patients has been published thus far.
An interdisciplinary approach that includes urologists,
pediatric nephrologists, pediatric intensivists and specia-
lized nurses is required during the perioperative period to
provide close follow-up and to prevent and treat the
potential clinical and surgical complications commonly
found in these patients. Herein, we aim to describe the
management of these patients in the early postoperative
period, thereby demonstrating a practical approach that can
increase the success rate of pediatric kidney transplantation
programs and decrease their morbidity rates.
& POSTOPERATIVE CARE
The immediate postoperative care for children after
kidney transplantation should occur in pediatric intensive
care units. In addition to general pediatric perioperative
care, the specific fluid, electrolyte and hypertension man-
agement in the first 24-48 hours after the transplant
procedure requires close attention from this specialized
team, particularly for small children.
The fluid management starts by replacing the daily
insensible losses (approximately 400 ml/m2 of the body
surface area) for the next 24 hours with dextrose and
sodium solution. The urinary output volume should be
monitored and replaced hourly with the same volume of
saline, Ringer’s lactate solutions or bicarbonate solution.
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Electrolyte disturbances can be anticipated and prevented
by closely monitoring (4-6 hours on the first day) the serum
electrolyte levels (5). When hypernatremia occurs, it can be
corrected by changing the replacement solution to 2/3 of
saline, Ringer’s lactate or bicarbonate solution (according
to serum bicarbonate levels) plus 1/3 dextrose solution. The
urinary sodium composition measurement can help guide
the concentration of sodium in the replacement solution.
Because of the volemic and high urinary output volume
changes that occur, calcium, magnesium, potassium and
phosphate must commonly be replaced (6).
In children with residual diuresis from native kidneys,
special attention is required because a malfunctioning or
nonfunctioning transplanted kidney can be overlooked.
The systolic arterial blood pressure should be above
100 mmHg to provide adequate perfusion of the allograft
in the first 24-48 h of intensive care. If additional crystal-
loid or albumin infusion is not enough to reach this
blood pressure and/or the central venous pressure is .5-
10 cmH2O, vasopressor, usually dopamine, should be
initiated. In this setting, mechanical respiratory support
may be needed to avoid pulmonary congestion symptoms
by maintaining higher arterial and central venous pres-
sures, particularly for small children who have received
adult allografts (6).
Arterial hypertension is also frequently observed during
this immediate postoperative period and may be related to
liberal fluid management, immunosuppressive drugs (e.g.,
calcineurin blockers), high doses of corticosteroids or previous
arterial hypertension. Calcium channel blockers are safe and
effective for blood pressure control at this time, as they can
reverse the vasoconstrictive effect of calcineurin inhibitors (7).
Intravenous dipyrone is routinely used for pain control,
and opioids can be added if the pain remains. Analgesia and
sedation can be performed with continuous intravenous
infusions of fentanyl and midazolam while the patient is on
mechanical ventilation.
Antibiotics are normally administered during the perio-
perative period to prevent wound infections. Dosing
commonly begins with cephalosporin, which is substituted
with co-trimoxazole. Co-trimoxazole is maintained to
prevent urinary infections and Pneumocystis carinii for
months. Antiviral prophylaxis against cytomegalovirus
(CMV) is recommended based on the donor and/or
receptor CMV serological status and the immunosuppres-
sion regimen (7).
The abdominal drain is not routinely left in the patient.
However, in cases of technical difficulty for ureteral
reimplantation or in patients at increased risk of bleeding
(e.g., postoperative anticoagulation therapy), the drain can
be helpful for early diagnosis and intervention. An increase
in the drain output can indicate urinary fistula, lymphor-
rhea or bleeding. Laboratory exams (i.e., urea, creatinine,
potassium and hematocrit) from the drain can help to clarify
these situations. Imaging exams, such as Doppler ultra-
sound and/or computed tomography, can also be helpful
in this initial evaluation, aiding in the assessment of renal
morphology and peri-renal collections (8). In general,
abdominal drains and bladder catheters are left in place
for at least 5-7 days; if the postoperative time is uneventful,
both are then removed.
Doppler ultrasound is performed at least once in the first
24 hours after the kidney transplantation. In cases of
unexplained decreases in the urinary output or worsening
arterial hypertension, imaging exams should be immedi-
ately repeated, as vascular thrombosis may be present (9).
Young recipient age, young donor age, hypercoagulo-
pathy, previous thrombosis in large vessels or thrombosis in
vascular accesses are all risk factors for graft thrombosis,
which is a significant cause of pediatric transplant loss.
Despite the fact that, because of the aforementioned reasons,
many pediatric transplant centers use heparin in the
immediate post-transplant period for children at risk of
thrombosis, thrombotic prophylaxis has not been estab-
lished in the literature (5).
The surgeon must regularly check the abdominal wound
because dehiscence and local infection are not uncommon
events (10). Furthermore, pain and swelling in the trans-
planted fossa can signify venous thrombosis or, even worse,
renal rupture.
& IMMUNOSUPPRESSION
Immunosuppressive drug therapies must begin before or
at the time of the kidney transplantation. In patients with
regular immunological risks, interleukin-2 receptor antago-
nist is generally used for induction, whereas in patients with
high immunological risks, T-cell depleting antibodies are
recommended (e.g., anti-lymphocyte preparations, such as
thymoglobulin).
The typical maintenance therapy consists of a calcineurin
inhibitor (tacrolimus or ciclosporin), an anti-proliferative
agent (mycophenolate or azathioprine) and steroids (11,12).
Tacrolimus has been shown to improve graft survival
when compared with cyclosporine, and low doses of
tacrolimus remain the favored approach to reduce long-
term calcineurin inhibitor nephrotoxicity. Although steroid
minimization strategies are attractive for children because
they could improve growth outcomes without increasing
acute rejection or lowering graft survival rates, limited long-
term follow-up data are available (13).
Early renal allograft rejection can cause delayed graft
dysfunction, and a kidney biopsy is important to confirm
this diagnosis and to determine the types of rejection to
provide proper treatment. The current treatments for acute
cellular rejection include steroid pulses or an infusion of T-
cell-depleting antibodies, while antibody-mediated rejection
is managed with plasmapheresis, intravenous immunoglo-
bulin and specific, adjustments in immunosuppression.
& AUTHOR CONTRIBUTIONS
Torricelli FC and Watanabe A wrote the manuscript. David-Neto E
critically revised the manuscript for intellectual content. Nahas WC
critically revised the manuscript for intellectual content and supervised the
study.
& REFERENCES
1. Goldstein SL, Rosburg NM, Warady BA, Seikaly M, McDonald R,
Limbers C, et al. Pediatric end stage renal disease health-related quality
of life differs by modality: a PedsQL ESRD analysis. Pediatr Nephrol.
2009;24(8):1553-60, http://dx.doi.org/10.1007/s00467-009-1174-1.
2. Wiwanitkit V. Outcomes and predictive factors of pediatric kidney
transplants. Pediatr Transplant. 2013;17(5):498, http://dx.doi.org/10.
1111/petr.12099.
3. Nahas WC, Antonopoulos IM, Piovesan AC, Pereira LM, Kanashiro H,
David-Neto E, et al. Comparison of renal transplantation outcomes in
children with and without bladder dysfunction. A customized approach
equals the difference. J Urol. 2008;179(2):712-6.
4. Gulati A, Sarwal MM. Pediatric renal transplantation: an overview and
update. Curr Opin Pediatr. 2010;22(2):189-96, http://dx.doi.org/10.
1097/MOP.0b013e32833683fd.
Postoperative care in pediatric kidney transplantation
Torricelli FC et al.
CLINICS 2014;69(S1):39-41
40
5. Goebel J. Renal Issues in Organ Transplant Recipients in the PICU. In:
Kiessling S, Goebel J, Somers MG, editors. Pediatric Nephrology in the
ICU: Springer Berlin Heidelberg; 2009. p. 247-59.
6. Pape L, Offner G, Ehrich JH, Sasse M. A single center clinical experience
in intensive care management of 104 pediatric renal transplantations
between 1998 and 2002. Pediatr Transplant. 2004;8(1):39-43, http://dx.
doi.org/10.1046/j.1397-3142.2003.00114.x.
7. Seikaly MG, Sanjad SA. Intensive care and immediate follow-up of
children after renal transplantation. Transplant Proc. 2001;33(5):2821-4,
http://dx.doi.org/10.1016/S0041-1345(01)02204-7.
8. Sutherland T, Temple F, Chang S, Hennessy O, Lee WK. Sonographic
evaluation of renal transplant complications. J Med Imaging Radiat Oncol.
2010;54(3):211-8, http://dx.doi.org/10.1111/j.1754-9485.2010.02161.x.
9. Gargah T, Abidi K, Rajhi H, Ben Abdallah T, Chebil M, Lakhoua MR.
Vascular complications after pediatric kidney transplantation. Tunis
Med. 2011;89(5):458-61.
10. Wszola M, Kwiatkowski A, Ostaszewska A, Gorski L, Kuthan R,
Sawicka-Grzelak A, et al. Surgical site infections after kidney transplan-
tation–where do we stand now? Transplantation. 2013;95(6):878-82,
http://dx.doi.org/10.1097/TP.0b013e318281b953.
11. David-Neto E, Araujo LP, Feres Alves C, Sumita N, Romano P, Yagyu EM,
et al. A strategy to calculate cyclosporin A area under the time-
concentration curve in pediatric renal transplantation. Pediatr Transplant.
2002;6(4):313-8, http://dx.doi.org/10.1034/j.1399-3046.2002.02019.x.
12. David-Neto E, Pereira Araujo LM, Sumita NM, Mendes ME, Ribeiro
Castro MC, Alves CF, et al. Mycophenolic acid pharmacokinetics in
stable pediatric renal transplantation. Pediatr Nephrol. 2003;18(3):266-
72.
13. Kim S, Webster AC, Craig JC. Current trends in immunosup-
pression following organ transplantation in children. Curr Opin Organ
Transplant. 2013;18(5):537-42, http://dx.doi.org/10.1097/MOT.0b013e3283
651b35.
CLINICS 2014;69(S1):39-41 Postoperative care in pediatric kidney transplantation
Torricelli FC et al.
41
